% | $
Quotes you view appear here for quick access.

BlackBerry Limited Message Board

arhdan9 4 posts  |  Last Activity: Jul 9, 2016 12:13 PM Member since: Mar 20, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • arhdan9 arhdan9 Jul 9, 2016 12:13 PM Flag

    The bottom line is if DCVax-L or D is proved to be better than any existing treatment in any indication in terms of safety and efficacy, it will be approved by FDA; even if L or D might be shown similar in efficacy and/or even safety to that of any existing treatment, it will still be approved by FDA as an alternative which can applied for specific patient populations.

    While one may get carried away from a useless debate, he or she must always remember that at $0.5 a piece per share, basically the market has priced the company a failed company, the L trial a failed trial, LP a failed ceo, and all long investors failed hairballs, and nothing less.

    Don't tell me the company will go bankrupt if you are genuine and have a bit biotech experience, only if LP had nefarious motive if you believe. A company like nwbo will not go bankrupt at foreseeable future, though it is a likelihood that the company will survive simply by diluting its existing share holders.

    Nonetheless, as long as the potentials of D still exist, as long as there is still likelihood that L may still be used in combinations with other agents such as CIs even if L is proven a failure in brain cancer indication, a market cap of around $100 million will be normal, which will give you roughly $1 per share of stock price.

    Not saying the company has not filed a BLA (rolling application or not), not saying the company has not sought AA, but what I am saying is the current situation indicated by share price has totally denied any possibility of those and regarded the company a failed company with a failed L trial.

    It is then a natural, logic, reasonable and certain conclusion as long as investment is concerned: buy nwbo shares as many as and as much as one can afford at this option price.

    It is either $0.5 loss or $30 gain or $300 gain.

  • arhdan9 arhdan9 Jul 7, 2016 5:50 PM Flag

    Sorry, I meant to say cancer hypnotherapy.

  • arhdan9 arhdan9 Jul 7, 2016 5:44 PM Flag

    Yes, good move re nwbo. On the other hand, people still don't understand it is still overly expansive of juno even with 30% haircut because the very concept of this class of treatment called cart-t is dead, not just this underlining p2 trial.

    Move your money to nwbo the only player left in town -- cancer hypnotherapy before stupid hedges do the same!

  • It has been long written on the wall but today's reveling is the last call for people to wake up to the fact. Don't look at Wall Street's (particularly the street AF's) endless bashing on nwbo. Please to have an in-depth DD on nwbo, and you will love it.

    The most wonderful thing is now you can pay option prices for nwbo shares thanks to endless, scandalous and orchestrated attacks on the company.

    NWBO is the future of cancer hypnotherapy!

7.98+0.040(+0.50%)Sep 30 4:00 PMEDT